BCTXZ NASDAQ
BriaCell Therapeutics Corp. Warrant
1W: +86.7%
1M: +55.1%
3M: +222.2%
YTD: +18.4%
1Y: +39.8%
$0.30
+0.14 (+83.95%)
Weekly Expected Move ±49.4%
$0
$0
$0
$0
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$148K
-29.7% ▼
Operating Income
-$38M
-81892.3% ▼
Net Income
-$36M
-551603.1% ▼
EPS (Diluted)
$-86.25
-1915.2% ▼
EBITDA
-$37M
-79705.7% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $148K |
| Gross Profit | $0 | $0 | $0 | $0 | -$148K |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $2M | $8M | $15M | $27M | $30M |
| SG&A Expenses | $5M | $7M | $8M | $6M | $8M |
| Operating Expenses | $7M | $15M | $23M | $33M | $38M |
| Operating Income | -$7M | -$15M | -$23M | -$33M | -$38M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $79K | $979 | $0 | $0 | $51K |
| Income Before Tax | -$14M | -$27M | -$20M | -$5M | -$37M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$14M | -$27M | -$20M | -$5M | -$36M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | $0.00 | $-86.25 |
| EBITDA | -$14M | -$27M | -$23M | -$33M | -$37M |
| Shares Outstanding | 0 | 0 | 0 | 0 | 423114 |